Global Financial Private Client, LLC Gilead Sciences, Inc. Transaction History
Global Financial Private Client, LLC
- $281 Billion
- Q3 2025
A detailed history of Global Financial Private Client, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Global Financial Private Client, LLC holds 8,156 shares of GILD stock, worth $1.01 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
8,156
Previous 7,826
4.22%
Holding current value
$1.01 Million
Previous $868 Million
4.34%
% of portfolio
0.32%
Previous 0.33%
Shares
17 transactions
Others Institutions Holding GILD
# of Institutions
2,370Shares Held
1.01BCall Options Held
8.63MPut Options Held
7.39M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...